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In radiation therapy of tumors in the thorax and abdomen, respiratory-induced motion 
creates challenges in different steps of the treatment, such as simulation, treatment 
planning, and the daily patient positioning. Different methods are clinically applied to 
reduce the impact of respiration in radiation therapy. However, most techniques involve 
invasive procedures or expose the patient to extra radiation. In this thesis, first, the 
application of combining stereotactic body frames with a surface imaging system for 
patient positioning in stereotactic body radiotherapy (SBRT) of lung cancer was evaluated. 
Stereotactic body frames are safe and non-invasive devices that reduce the impact of 
respiratory-induced motions by decreasing the range of the tumor motion. Surface imaging 
systems are also safe and dose-free technologies for patient positioning that have the ability 
to monitor the patient’s motion during radiation delivery with high precision. Combining 
the use of a surface imaging system with SBRT positioning frames adds another level of 
accuracy to patient setup and provides monitoring of the movements during treatment. The 
results of this evaluation indicated difficulty in using surface imaging with SBRT frames 
primarily due to the presence of the compression plate. 
Next, a patient-specific correspondence model was developed to track tumors in the thorax 
during radiation therapy treatments using surface displacement as the surrogate signal. The 
proposed model is made prior to the treatment for each patient. Two types of data are used 
for model construction: Four-dimensional computed tomography (4DCT) images of the 
patient and the displacement of two points on the patient’s skin on the thoracic area 
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(surrogate signals). The two types of data are acquired simultaneously. The 4DCT images 
are sorted by the amplitude-binning algorithm to account for hysteresis and breathing 
irregularities. A deformable image registration algorithm is applied to the 4DCT images to 
calculate the deformation vector fields as the knowledge of the patient’s internal motion. 
Principal component analysis is used to fit the correspondence model. The model 
incorporates recorded surrogate signals during radiation delivery as an input and delivers 
the 3D trajectory of the tumor or other anatomy of the interest. This model accounts for 
hysteresis and irregular breathing. The accuracy of the proposed model was evaluated on 
a respiratory phantom and five lung cancer patients. The results showed a primary 
validation for localizing the tumors in the lung. Testing the model on a larger population 
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1.1. Motion Management in Radiation Therapy 
Recent advances in modern radiation therapy have resulted in delivering a more focused 
beam to the tumor with a sharp radiation dose gradient [1]. Therefore, to deliver the 
maximum radiation dose to the tumor while sparing the organs at risk and healthy tissues, 
a precise measure of the tumor location is critical. Image-Guided radiation therapy (IGRT) 
uses imaging techniques to localize and monitor the location of the target volume before 
and during the radiation treatment. Inter-fraction errors and intra-fraction motions are the 
main factors that affect the location of the target volume. Inter-fraction errors are variations 
in target location that take place in day-to-day treatments. Intra-fraction motions are the 
movements of the target during radiation treatment that are usually caused by the 
respiratory, cardiac, muscular, and gastrointestinal systems. Respiratory-induced motion, 
however, remains one of the challenges in IGRT, and many studies have been undertaken 
to solve the treatment delivery limitations that arise by motions due to respiration. For 
imaging of the tumors in the thorax and abdomen, respiratory motion reduces the image 
quality and causes artifacts [2], [3]. The respiratory motion also affects the accuracy of 
treatment planning [4], dose calculations [5], and quality of the radiation delivery.  
 2 
In treatment planning, margins are added to the clinical target volume (CTV) to account 
for respiratory motions. However, this means a larger field size is needed, and as a result, 
more healthy tissue will receive high radiation doses [6].  
There are suggested methods to decrease the effect of respiratory motion. All methods are 
described below in detail using the classification provided by AAPM Task Group 76 [6].  
 
1.1.1 Motion Encompassing Methods 
One of these methods is motion-encompassing. In this method, the target’s mean position 
and range of motion are assessed while computed tomography (CT) imaging. Three 
techniques that are used to estimate the target’s range of motion include slow CT scanning 
[7]–[9], Inhalation and exhalation breath-hold CT [2], [10], [11], and four dimensional 
computed tomography (4DCT)/respiratory correlated CT (RCCT) [12]–[16]. In the slow 
CT scanning technique, the CT scanner is running very slow such that more than one 
respiration phases are recorded in each slice. Therefore, the target’s full range of motion 
should be apparent in the CT image. However, since the respiratory motion might change 
from simulation day to treatment day, additional margins are required to compensate for 
these changes. One of the disadvantages of this technique is motion blurring. The slow 
scanning technique is usually used to scan peripheral lung tumors. But, due to motion 
blurring, it is not suitable for imaging the tumors that are near the mediastinum and/or chest 
wall. This technique is also not recommended for tumors other than lung tumors such as 
kidney, pancreas, or liver.  
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One of the common techniques to estimate the target’s range of motion is inhalation and 
exhalation breath-hold CT. In this technique, on the simulation day, both inhalation and 
exhalation-gated or breath-hold CT scans are acquired from the patient. Since two scans 
are acquired, image fusion and additional contouring are needed. The maximum intensity 
projection (MIP) [17] tool, which is available in many of the visualization systems, is 
utilized to acquire the tumor-motion-encompassing volume for lung tumors. Acquiring 
both inhalation and exhalation scans takes more than double the CT scanning time, and 
depends on the patient’s ability to hold his/her breath reproducibly. However, in this 
technique, the motion blur is less than slow scanning technique.  
The third technique in the motion-encompassing method is 4DCT or RCCT. The tumor’s 
mean position, range of motion, and characteristics of the motion [15] can be calculated 
from the 4D data. Variations in the respiratory pattern during 4D image acquisition may 
cause artifacts. Methods such as breathing-training are developed [18] to solve the 
respiratory pattern variation limitation; however, artifacts may still be seen [19]. 
All of the techniques that are mentioned above increase the radiation dose to the patient by 
2-15 times that of a standard CT simulation procedure.  
 
1.1.2 Respiratory Gating Methods 
Respiratory gating methods decrease the impact of respiratory motion. In respiratory 
gating, the radiation is delivered in a specific portion of the patient’s respiratory cycle, 
which is called the “gate.” Respiratory gating is performed both during imaging and 
treatment delivery. The patient’s respiratory motion is monitored by an external respiratory 
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signal or an internal fiducial marker to determine the position and the width of the gate 
within the respiratory cycle. In gated techniques, the imaging or treatment procedures’ time 
increases since the radiation delivery is not continuous. However, one of the advantages of 
the gated methods is that the planning target volume (PTV) margins could be decreased 
since the imaging and treatment procedures are synchronized with the patient’s respiratory 
cycle.  
Two variables are defined for respiratory motion, amplitude and phase, and they are 
recorded through the respiratory signal or the internal anatomy motion. Thus, gating 
methods are divided into two categories; amplitude-gating, and phase-gating. The 
amplitude of the respiration signal is measured as the relative position of the signal between 
end-inhalation and end-exhalation. In amplitude-gating, the radiation delivery is performed 
each time the respiratory signal is within a preset window of relative positions. The phase 
of the respiration signal is calculated from the respiratory signal by an algorithm that must 
meet the frequency criteria. Each complete respiration is considered as a phase interval 
between 0 and 2, with 0 as the end of inhalation and  as the end of exhalation. In the 
phase-gating, the radiation delivery is performed each time the respiratory signal is within 
a preset phase window.  
Usually, the gate window covers that part of the respiratory cycle that tumor’s motion is 
estimated to be less (i.e., end of exhalation) or the part of the respiratory cycle that the 
lung’s volume is maximum (i.e., end of inhalation).  
The efficiency of the gating method is measured by the duty cycle. The duty cycle is 
defined as the ratio of beam-on time to the entire treatment time. Smaller duty cycle leads 
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to smaller treatment margins. However, the overall treatment time increases, and this 
increases the likelihood of patient motion due to discomfort [20].  
Despite gating, there is still some tumor motion within the gate window which is called 
residual motion [21]. The choice of gate width is generally compromised by the balance 
between the amount of residual motion and duty cycle. 
 
1.1.3 Breath-Hold Methods 
The third series of methods to reduce the effect of respiratory motion are breath-hold 
methods. These methods are commonly used in lung cancer radiotherapy, and they also 
have some advantages in breast cancer radiation therapy. Breath-hold methods include five 
types of techniques, deep-inspiration breath hold (DIBH) [22]–[24], active breathing 
control (ABC) [25], [26], self-breath hold without respiratory monitoring [27], [28], self-
breath hold with respiratory monitoring, and breath hold in combination with intensity 
modulated radiation therapy (IMRT).  
Deep-inspiration breath hold can efficiently reduce the tumor motion in the thorax. A deep-
breath hold usually can alter the anatomy in a way that healthy organs at risk are protected. 
In the DIBH technique, the patient is verbally coached to a reproducible state of deep inhale 
breath hold both on simulation day and treatment day. One of the DIBH limitations is that 
many of the patients are not able to repeat the breath-hold reproducibly enough to permit 
its use.  
Active breathing control technique eases the reproducibility of the breath-hold. In this 
technique, the air flow during the respiratory cycle is monitored by a spirometer. The air 
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flow stops at a preset threshold volume by the ABC apparatus, and this helps the patients 
to maintain their breath at this volume [26], [29]. The duration of breath-hold depends on 
the patient, but it is usually between 15 and 30 seconds.  
The choice of threshold volume is usually either moderate inhale or deep inhale. In 
moderate DIBH (mDIBH), the threshold volume will be set at 75% of deep inhale. This 
increases the reproducibility of the internal organ displacement and also retains the 
patient’s comfort [25], [30], [31].  
In self-breath hold without respiratory monitoring technique, the patient holds their breath 
at a specific point in the respiratory cycle and simultaneously enable the treatment beam 
by pushing a switch connected to a control system. This allows the therapist to activate the 
radiation beam. The beam can be turned off by both the patients (when they aims to stop 
holding their breath) and the therapist. Based on previous studies, deep inhalation and deep 
exhalation are the most reproducible states of respiration. However, since deep inhalation 
has dosimetric advantageous due to the reduction in lung density, deep inhalation is usually 
the choice of the breath-hold position [22]. 
 In self-breath hold with respiratory monitoring technique, the patient holds his/her breath 
at a specific point in the respiratory cycle; however, the patient’s respiration is monitored 
continuously. If the patient’s breath-hold level deviates from the preset level, the beam will 





1.1.4 Forced Shallow Breathing with Abdominal Compression 
Forced shallow breathing (FSB) was first developed for stereotactic radiation therapy of 
small targets in the lung and liver [32]–[34]. However, it also could be used for 
conventional lung treatments. In this technique, a stereotactic body frame (SBF) is used to 
immobilize the patient. The SBF consists of a rigid frame and a vacuum pillow. The 
vacuum pillow is costom fitted to each patient. A compression plate is attached to the frame 
that is pressed against the abdomen to limit the diaphragmatic motion. A bar is attached to 
the SBF to support the compression plate. 
On the simulation day, the motion of the tumor in the craniocaudal direction is evaluated 
by a fluoroscopic simulator. If the motion of the tumor exceeds 5 mm, the compression 
plate is put on the patient’s abdomen in a way that the two upper angled sides of the plate 
are placed at 2 – 3 cm below the triangular rib cage. The position of the bar connected to 
the compression plate is recorded from the scales on both sides of the frame to be 
reproduced on the treatment day. The position of the plate is also reproduced by recording 
the scale mark on the screw that controls the location of the plate. 
 
1.1.5 Real-Time Tumor Tracking Methods 
Another method to reduce the impact of the respiratory motion is real-time tracking. In 
real-time tracking, the radiation beam’s position is changing dynamically to follow the 
tumor’s position. An ideal real-time tracking can reduce the treatment margins 
substantially. A successful real-time tracking must be able to do four things: 
a) recognizing the location of the tumor in real-time, 
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b) predicting the motion of the tumor to permit for the time delays that beam-
positioning system needs to respond, 
c) repositioning the radiation beam, 
d) Tuning the dosimetry in order to follow the variation of the lung volume and 
location of the critical organs during respiration. 
In real-time tumor tracking, the most challenging step is identifying the location of the 
tumor. One way to track the tumor position during radiation delivery is imaging the tumor 
by an imaging modality such as fluoroscopy. However, for most tumors in the lung, liver, 
and pancreas, it is only possible to detect the tumor in fluoroscopy (or radiographic) images 
in specified positions. And, the detected tumor is not always a high contrast object that can 
be used in automatic segmentation or image registration. Therefore, fiducial markers are 
implanted in lung, liver, or pancreas tumors [35]–[38]. Markers are usually made from one 
of the high-Z metals (e.g., gold). The number of markers implanted in a tumor is often 
more than three. More than three markers not only allow the measurement of both 
translation and rotation of the tumor, but it also helps to monitor the possible migration of 
the markers by measuring the distance between them. Real-time tracking with imaging 
causes extra radiation dose to the patient. Therefore, a combination of episodic x-ray 
imaging and continuous monitoring of external respiratory signals are suggested to reduce 
the exposure to the patient. 
It is not always possible to track the tumor location continuously by x-ray imaging. An 
alternative is to estimate the position of the tumor from an external respiratory signal. The 
correlation between internal and external motion can be found before treatment. This 
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correlation is not always simple and stationary. Thus, the correlation should be monitored 
and updated during the treatment by respiratory signals and occasional imaging.  
Another real-time tumor tracking technique is non-radiographic tracking of an active or 
passive device that is implanted in the tumor [39], [40]. In this technique, a powered 
radiofrequency coil is implanted inside the tumor. This coil could be tracked 
electromagnetically in three dimensions. The advantage of this technique is that it is dose-
free and, therefore, could be a substitute to track tumors with x-ray imaging. 
Compensating for time-delays in the beam-positioning response is another important 
characteristic that a real-time tracking technique should possess. Image acquisition, data 
readout, image processing needed to locate the marker, triggering the beam operation, and 
required time for beam repositioning all are obstacles to the instantaneous beam-
positioning response. A 90 ms delay between marker recognition and the start of a gated 
radiation beam has been reported [41]. Therefore, there is a need to predict the location of 
the tumor in advance. Although there are variations in the cycle to cycle of human 
breathing, these variations are not purely random [42], and the tumor location can be 
predicted accurately by up to 80% [37].  
For real-time tracking to be performed, there should be the possibility of beam 
repositioning. Currently, there are three beam repositioning systems, multi-leaf collimator 
(MLC) [43]–[47], robotic-arm-mounted linear accelerator (LINAC) [35], [36], [48], [49], 
and Gimbaled x-ray head [50]–[52]. In the second approach, an imaging system monitors 
the location of the tumor. The robotic-arm is coupled to the imaging system through a 
control loop that navigates the repositioning of the beam.  
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Respiratory-induced motion has an impact on both the quality and quantity of the radiation 
therapy dose distributions [53]. The images that are used for dosimetry in treatment 
planning are only an instant presentation of anatomies of the patient. However, during 
radiation delivery, there are continuous variations in anatomy and the air volume in the 
lungs. This will disturb the beam attenuation and also alter the relative location of the 
tumor, normal tissues, and critical structures. Although the impact of the respiratory-
















1.2. Surface Guided Radiation Therapy 
Surface guided radiation therapy (SGRT) is one of the rapidly growing modalities of IGRT. 
Surface guided technologies have significantly improved the accuracy of patient 
positioning and real-time tracking in radiation therapy. Surface imaging systems have 
several advantages. They are dose-free and non-invasive and can monitor the patient’s 
position during the treatment. They also can monitor and record respiratory signal as 
surrogate to use in motion management strategies.  
In surface guided techniques, a reference surface image of the patient is recorded on the 
simulation day. On the treatment day, a live surface image of the patient is registered to the 
reference image that is correlated to the isocenter of the radiation delivery system. 
The main principle of surface imaging systems is stereophotogrammetry. In this technique, 
a 3D image is reconstructed from multiple 2D images with known spatial geometry 
information. Different types of surface imaging systems are explained below in detail. 
 
1.2.1. Video-Based Positioning Systems 
The video-based patient positioning technique was one of the first surface imaging 
approaches developed and clinically implemented [54]. In this technique, on the simulation 
day, after the patient was set up accurately, a reference image is acquired from the patient. 
On the treatment day, the reference image is subtracted from the real-time images of the 
patient during the patient setup. The basic system includes three wall-mounted cameras 
and one ceiling-mounted camera that provide a favorable large field of view (FOV) of the 
patient (Figure 1-1) 
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The video image subtraction approach provides a quick, easy to use, accurate, and intuitive 
way for patient positioning/setup in radiation treatment. Clinical experience of using video-
based patient positioning system in head and neck radiotherapy showed setup error 
between 1 to 3 mm [55]. 
 
 
Figure 1-1. A schematic view the locations of the cameras in video-based positioning 
system (figure from Milliken et. al. 1997 [54]) 
 
 
1.2.2. Laser-Based Positioning Systems 
Another approach developed for more accurate and reproducible patient positioning in 
radiation therapy employs a 4D laser scanning system to record the surface image of the 
patient [56]. This laser scanning system is now commercialized as Sentinel 4DCT (C-RAD 
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AB, Uppsala Sweden). Sentinel has a laser scanning system to scan the patient’s surface 
and a camera to detect the reflection of the laser from the patient’s surface (Figure 1-2). 
Sentinel is also capable of recording the respiratory surrogate signals, which can be used 
for 4DCT reconstruction and retrospective and prospective gating purposes. 
 
Figure 1-2. Sentinel. The laser scanner scans the patient’s surface while the camera detects 
the reflection of the laser from patient’s surface. (figure courtesy of C-RAD). 
 
Another commercially available laser-based positioning system is Galaxy (LAP Laser, 
Luneburg, Germany). The Galaxy’s technology is similar to Sentinel, and a study on 
healthy volunteers shows that its lowest observed accuracy is between 1.70 to 0.15 mm 
[57].  
 
1.2.3. Optical-Based Positioning Systems 
The majority of commercially available patient positioning systems use optical cameras. 
In optical-based positioning systems, a structured pattern of light is projected on the 
patient’s surface by a camera, and the reflection of the light from the patient’s surface is 
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detected by another camera to reconstruct the patient’s surface image. Then a 6D matching 
software measures the shifts between the real-time image and the reference image (which 
is captured on the simulation day).  
One of the commercially available optical-based positioning systems is AlignRT (Vision 
RT, London, UK). In AlignRT technology, a camera projects a speckle pattern light on the 
patient’s surface, and another camera detects the distortions of the known projected speckle 
light pattern (Figure 1-3.a). Both cameras are installed inside one unit and calibrated to the 
treatment isocenter. For a desirable field of view of the patient’s surface in spite of gantry 
rotation, three units are mounted on the ceiling of the treatment room with 90-degree 
between the units (Figure 1-3.b).  
 
Figure 1-3. An image of the AlignRT unit (a) and the visualization of three AlignRT units 
mounted on the ceiling of the radiation treatment room (b) (figure from Alaei and Ding 




The reconstructed surface image consists of triangular surface tiles and, therefore, has the 
geometry information of the surface [59]. The reconstructed real-time surface images are 
registered to the reference image acquired on the simulation day or on the first treatment 
day using a 6D matching software. The matching software employs the iterative closest 
point (ICP) registration algorithm to find 6D correction vectors that match the reference 
image to the live image on treatment day. After setting up the patient accurately and 
matching the reference image isocenter with the treatment isocenter, the patient can be 
translated or rotated by up to 1 mm or 1 degree from the treatment isocenter [59], [60]. 
AlignRT cameras monitor the patient actively during the radiation delivery. AlignRT has 
a beam-hold interface feature. In this case, if the patient moves outside a pre-defined 
tolerance, the beam can be put on hold by the software.   
Another commercially available optical-based positioning system is Catalyst HD (C-RAD 
AB, Uppsala Sweden). Each unit of the CatalystHD has a projector that uses a light-
emitting diode (LED), and a detector camera consisting of a charge-coupled device (CCD) 
for the reflected light from the patient’s surface [61] (Figure 1-4.a). In CatalystHD, optical 
visible light is projected on the patient’s surface with a striped pattern. Depending on the 
geometry of the radiation delivery system, between one to four CatalystHD units can be 
mounted on the treatment room ceiling (Figure 1-4.b).  
When the patient’s surface is reconstructed, a 6D matching software employs a deformable 
image registration (DIR) algorithm to register the live image with the reference image. 
After setting up the patient accurately and matching the reference image isocenter with the 
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treatment isocenter, the patient can be translated or rotated by up to 1 mm or 1 degree from 
the treatment isocenter [62].  
CatalystHD cameras monitor the patient actively during the radiation delivery. 
CatalystHD’s beam-hold interface feature will put the radiation beam on hold if the patient 
moves outside a pre-defined tolerance.  CatalystHD is capable of recording the respiratory 
surrogate signals, which can be used for gating purposes. 
 
 
Figure 1-4. An image of the CatalystHD unit (a) and the visualization of three CatalystHD 




IDENTIFY (Varian Medical Systems, Palo Alto, CA) is another commercially available 
optical positioning system (Figure 1.5). The basic technology of the IDENTIFY is the same 
as AlignRt and CatalystHD. Each Identify unit is consists of a projector and a pair of 
cameras for detecting the projected light from the patient’s surface.  
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After surface reconstruction, a 6D matching software employs a rigid image registration  
algorithm to register the live image with the reference image. IDENTIFY can monitor the 
patient’s movements during the treatment and can record the respiratory signals for gating 
treatments. 
 










1.3.  Goals of the Study 
 
The main goal of this project was to evaluate the use of surface guidance to decrease the 
impact of respiratory-induced motion in radiation therapy of lung cancer patients with the 
ultimate aim of reducing the use of x ray-based imaging. Chapter 2 discusses the possibility 
of combining the use of stereotactic body frames with surface guidance. Chapter 3 
represents the development of a patient-specific correspondence model to track the tumors 
in the lung during radiation delivery. This chapter discusses the evaluation of the accuracy 
of the model on a respiratory phantom and several lung cancer patients. Chapter 4 
















2.Evaluation of Combining CatalystHD with 
Stereotactic Body Frames for Patient 
Positioning in Lung Radiation Therapy 
 
2.1. Introduction 
In stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR), a 
focused radiation beam is delivered in a small number of fractions [63]. To reduce the 
target’s treatment margins and, therefore, to spare the tumor’s peripheral healthy tissues, 
two tasks are necessary: an accurate and reproducible patient positioning (minimizing the 
inter-fraction errors), and tracking the patient and the target’s motions (intra-fraction 
motions).  
Stereotactic body frames are used for patient immobilization and to reduce the motion 
during radiation therapy of lung tumors [32]. The application of the stereotactic body frame 
improves the accuracy of the radiation delivery by reducing the range of the tumor motion 
and increasing the reproducibility of the patient setup [64], [65]. 
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Cone beam computed tomography (CBCT) images are conventionally used for patient 
positioning in radiation therapy. Although CBCT scans are currently the most accurate 
patient positioning techniques, they expose the patient to extra x-ray radiation. Moreover, 
CBCT scans cannot be utilized for tracking the intra-fraction motions.  
Recently, surface imaging systems have been employed for patient positioning in 
radiotherapy. Not only are they dose-free, but they can also monitor the patient’s 
movements during the radiation delivery. Studies have shown that surface imaging systems 
can detect patient positioning errors with good accuracy and reproducibility [66]–[69]. 
Therefore, the application of surface imaging systems can potentially decrease the 
frequency of CBCT scans [62]. 
In this section, the suitability of CatalystHD in combination with stereotactic body frames 
was investigated for patient positioning and intrafraction motion tracking in lung cancer 
radiation therapy. 
 
2.2. Materials and Methods 
Three commercially available immobilization systems were employed, Elekta Body Frame 
(Elekta AB, Stockholm, Sweden),  Civco body Pro-lok (CIVCO Medical Solutions, 
Orange City, IA, USA), and Bionix Omni V (Bionix Development Corporation, Toledo, 
Ohio, USA) stereotactic body frame.  
An anthropomorphic Rando phantom (Alderson Research Laboratories, Stanford, CT) was 
covered with a white sheet in order to be visible to the SIGRT cameras (Figure 2-1). After 
placing the phantom on a Vac-Lok (CIVCO Medical Solutions, Orange City, IA, USA) 
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vacuum cushion, the phantom and the cushion were both positioned inside each frame and 
setup on the Philips Brilliance Big Bore CT scanner’s (Philips Medical Systems, 
Cleveland, OH) couch. The phantom was CT scanned, and a surface image was recorded 
using C-RAD Sentinel to create the reference image dataset. The CT images were exported 
to the Pinnacle treatment planning system (TPS) (Philips Radiation Oncology Systems, 
Fitchburg, WI), where external contours were generated and exported to the C-RAD 
system to use as reference images.  
 
  
Figure 2-1. A anthropomorphic Rando phantom covered with a white sheet in order to be 
visible to the SIGRT cameras. The phantom was positioned on a Vac-Lok vacuum 
cushion. 
 
In the treatment room, each setup was reproduced in a Varian Truebeam LINAC (Varian 
Medical Systems, Palo Alto, CA) room equipped with C-RAD Catalyst HD system.  The 
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surface area of the phantom visible using each frame was assessed. In the case of Bionix 
Omni V frame, both the rigid plate and the respiratory belt were examined. The placement 
of a respiratory trace was also evaluated. 
 
2.3. Results 
Figure 2-2, Figure 2-3, Figure 2-4, and Figure 2-5 show the phantom setup on the treatment 
room and the surface images recorded by Catalyst. 
 
Figure 2-2. Illustration of phantom setup on the treatment room using Bionix Omni V 





Figure 2-3. Illustration of phantom setup on the treatment room using Bionix Omni V 





Figure 2-4. Illustration of phantom setup on the treatment room using Civco body Pro-lok 






Figure 2-5. Illustration of phantom setup on the treatment room using Elekta Body Frame 
stereotactic body frame and compression plate (a), and the surface image recorded by 
CatalystHD (b). 
 
The phantom surface area visible to the CatalystHD cameras varies depending on the 
immobilization frame used. The surface area in Bionix Omni V frame provides the largest 
visible area. Due to the variations of the colors of the frames, there are obvious differences 
in the amount of reflection of each frame and the degree in which they obstruct the skin 
rendering. Depending on the color of the SBRT frame and its contrast with the surface, the 
frame may be automatically excluded from the surface allowing only the phantom surface 
to be monitored by the CatalystHD camera. However, compression plates in all three 





SBRT frames increase the precision of patient positioning and decrease the uncertainty of 
target tracking by reducing the intra-fraction motions. Combining the use of CatalystHD, 
and volumetric imaging with SBRT positioning frames adds another level of accuracy to 
patient setup and provides monitoring of the movements during treatment. The utility of 
the surface imaging with SBRT frames, however, is limited by the obstruction of the 


















3.A Patient-Specific Correspondence Model 




The main goal of a radiation therapy treatment plan is to deliver the maximum radiation 
dose to the tumor while sparing the organs at risk. A precise measure of the tumor location 
is crucial for achieving this goal. For many treatment sites, respiratory-induced motion 
makes the measurement and tracking of the exact tumor location more difficult during 
radiation delivery.  
Different methods have been developed to locate the tumor during radiation delivery. 
Among these methods, real-time tumor tracking by implanted markers and fluoroscopy 
have been found to be very accurate [70], [71]. As bones and other high density structures 
block the tumor, imaging the tumor by x-ray (fluoroscopy) alone is challenging [72], [73]. 
Therefore, fiducial markers are often implanted into or adjacent to the tumor. However, 
these methods include additional risks and complications, such as extra radiation exposure 
to the patient and invasive fiducial marker implantation procedures. Another disadvantage 
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of tracking tumors by fluoroscopy and markers is the possibility of markers’ migration 
from the implantation site [74]. 
In one type of gated radiation therapy, the beam is switched off when the tumor exits the 
target region (e.g., during inhalation) and switched on when it moves back to the target 
region. Although gated radiation therapy can increase the efficacy of radiation delivery 
despite organ and tumor motion, this method of gating increases the treatment time [75]. 
Also, there can be a time delay between when the beam turns on and the time of marker 
identification that would affect the accuracy of the treatment [38], [76].  
Tracked treatments are another type of gated radiation therapy, and include robotic-arm-
mounted linear accelerator (LINAC) and dynamic multi-leaf collimator (MLC) treatment 
deliveries. These can successfully reduce the planning target volume (PTV) margins and 
therefore reduce the exposure to the healthy tissue around the target as they actively modify 
the treatment delivery. However, imaging the tumor during radiation therapy is not always 
straightforward. For some lung tumors, only x-ray images from particular angles can 
reliably point out the location of the tumor [49], [77].  
An alternative approach is to calculate the location of the tumor during treatment. This may 
be done by finding a correlation between internal motion (motion of the tumor) and one or 
more respiratory surrogate signals such as spirometry or displacement of the patient’s chest 
or abdomen [78]–[85] This correlation is often expressed as a correspondence model and 





Figure 3-1. Demonstration of how a correspondence model is typically made (figure from 
Ehrhardt and Lorenz (Eds.), 2013[75]). 
 
 
Internal motion is often measured by performing image processing techniques on images 
from modalities such as magnetic resonance imaging [86]–[88] (MRI), four dimensional 
computed tomography (4DCT) [78], [79], [89], cone-beam CT [90] (CBCT) and 
fluoroscopy [91], [92].  
A high-quality surrogate signal is easy to measure throughout the radiation delivery, so the 
correspondence model gives the estimation of the tumor location [75]. There are different 
choices of surrogate signals. Some studies use internal surrogate signals, which are mostly 
derived from the patient’s images, such as displacement of some points of the internal 
anatomy like the diaphragm [89]. Although the correlation found would be stronger 
compared to the use of external surrogate signals, updating these signals during radiation 
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delivery might be challenging due to the poor quality images. In addition, they introduce 
more radiation exposure to the patient. In contrast, external surrogate signals such as 
displacement of the patient’s chest or abdomen can be measured directly. These are 
favorable since they are easy to measure during the course of treatment and do not include 
further exposure or invasive procedures.  
Presented here is a method to develop a patient-specific correspondence model to calculate 
tumor location in the chest during radiation treatment. The proposed model is made prior 
to the treatment for each patient. 4DCT images of the patient are used as the knowledge of 
the patient’s internal motion, and the displacement of two points on the patient’s skin in 
the thoracic area are selected as surrogate signals. The two types of data are acquired 
simultaneously. Principal Component Analysis (PCA) [93], is used to fit the 
correspondence model. The model incorporates surrogate signals as input and delivers the 
3D trajectory of the tumor center voxel or any other voxel of interest as output. The 
accuracy of the model was evaluated on a respiratory phantom and lung cancer patients.  
Twenty patients with lung cancer were entered into our study. However, due to limitations 
and technical problems (inaccurate data acquisition, improper placement of the primary 
and/or secondary signal location, equipment malfunction), only the data of five patients 
were complete and usable for the study.  
This study was approved by the University of Minnesota Institutional Review Board (IRB), 
and all patients provided consent to be included in the study.  
The patient treatments were not gated and patients were instructed to breathe normally 
during both the 4DCT acquisition and treatment. 
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This model offers a non-invasive and dose-free technique for tumor tracking with potential 
to enter clinical use due to its utilization of a commercially available system. This chapter 
first explains the general method to develop the correspondence model. Then, it discusses 
the evaluation of the model on a respiratory phantom and patient data.  
 
3.2. Materials and Methods 
Figure 3-2 demonstrates the framework of the correspondence model proposed here. After 
acquiring the imaging data and surrogate signals simultaneously, both types of data are 
processed to extract the internal/tumor and external data. Principal Component Analysis 
(PCA) is used to construct the correspondence model. On the treatment day, the surrogate 
signals are recorded and placed into the correspondence model to calculate the 3D location 




Figure 3-2. A simple representation of the framework of the proposed correspondence 
model. The model calculates the location of the center of the tumor in three directions, 







3.2.1. Data Acquisition for Model Construction 
During CT simulation procedure, Sentinel recorded the displacements of two points on the 
skin surface in anterior-posterior (AP) direction as surrogate signals. The two surrogate 
signals were recorded as “primary signal” and “secondary signal.” For all patients, the 
primary signal was located on the patient’s skin approximately on the xiphoid process, and 
the secondary signal was located about 2 cm superior to the primary signal.  Figure 3-3 
shows the location of the primary and secondary signals on one of the patients in the study. 
Figure 3-4 shows the recorded primary and secondary signals for this patient. The 
respiratory signals were then exported from C-RAD software and imported to MatlabTM 
(The MathWorks Inc., Natick, MA) for processing.  
 
 
Figure 3-3. Illustration of the surface image of the patient no. 3 in the study recorded by 
Sentinel on the simulation day. The location of the primary and secondary signals is shown 




Figure 3-4. Primary and secondary signals recorded for patient no. 3 in the study. The 
4DCT acquisition period is identified by red on the signals. 
 
While recording the surrogate signals, a helical 4DCT image was acquired (120 kVp, 800 
mAs/slice, FOV 600 mm) using a Philips Brilliance Big Bore CT scanner. Timestamps for 
the beam-on and beam-off periods of 4DCT acquisition were recorded by a stopwatch. The 
primary signal was used to reconstruct the 4DCT images retrospectively. The 4DCT 
images were sorted into ten respiratory phases (i.e., 0%, 10%, 20%, . . ., 90%) using vendor 
supplied amplitude-binning algorithm with the 0% as end of inhalation (EI) and 50% as 
end of exhalation (EE). There are two available vendor supplied binning algorithms, phase-
binning algorithm, and amplitude-binning algorithm. In the phase binning algorithm, the 
local maxima on the respiratory signal are identified and tagged as EI. The interval between 
each two consecutive EI points is a complete respiratory cycle. Therefore, other respiratory 
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phases are identified by locating their correspondence phase value on the temporal axis. 
That is, 10%, 20%, . . ., 90% corresponding to phase values /5, 2/5, …, 9/5 (Figure 
3-5.a). In the amplitude-binning algorithm the amplitude of the respiratory signal is used 
for the binning process. In this algorithm after identifying all local minima and maxima on 
the respiratory signal, the amplitude of the EI and EE phases are calculated separately. 
Therefore, the amplitude-binning algorithm account for hysteresis effect and potential 
irregular breathing [94]. All other respiratory phases with the same amplitude are identified 
on the distance between EI and EE phases (Figure 3-5.b).  
 
Figure 3-5. Illustration of phase-binning algorithm (a) and amplitude-binning algorithm (b) 
on the respiratory signal. 
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After 4DCT reconstruction, the image in each respiratory phase is 512 × 512 pixels × 𝑛 
slices with voxel size 1.17188 × 1.17188 × 3 𝑚𝑚3. 4DCT images were exported from 
the CT scanner in DICOM format for further processing.  
 
3.2.2. Surrogate signal Processing 
The aim of processing the surrogate signals was to find the average displacement 
(amplitude) of the patient’s skin surface at each respiratory phase at the location of primary 
and secondary signals. In other words, after processing the surrogate signals, the surrogate 
signal vector 𝑆𝑖 = [𝑠1,𝑖 , 𝑠2,𝑖]
𝑇
was constructed at each time point 𝑖, where 𝑠1,𝑖 and 𝑠2,𝑖  are 
the average amplitude of the patient’s skin surface at primary and secondary signal 
locations, respectively at timepoint 𝑖 (𝑖 = 1,2, … ,10, for 10 respiratory phases). 
Multiple pre-processing steps were applied to the signals. To remove the low-frequency 
components of the signals and to eliminate the baseline drifts, a high-pass filter was 
applied. Next, a Savitzky-Golay smoothing filter was applied to remove noise and smooth 
the signals. Using the beam ON and OFF timestamps, the period of the signals in which 
the beam was ON (4DCT acquisition period) was extracted to calculate the magnitude of 




Figure 3-6. 4DCT period of the primary and secondary signals for patient no. 3 in the study. 




To find the average amplitude of skin surface at each respiratory phase, the amplitude 
binning algorithm was chosen. First, for each signal, on the trace of amplitude vs. time, all 
the minima and maxima were located. Then the average amplitude of all minima and the 
average amplitude of all maxima were calculated and set as extremities (Figure 3-7). 
Therefore, to compute the average amplitude of 0% and 50% phases, the amplitude of any 
maximum or minimum that exceeded these limits was replaced by the magnitude of the 
average amplitude of the maxima or minima. This process would exclude any shallow or 
deep breaths of the patient.  
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Figure 3-7. For calculation of average amplitude of each respiratory phase, after identifying 
all the minima and maxima on each signal, the average amplitude of maxima and the 
average amplitude of all minima were calculated and set as extremities (signals in the image 
from patient no. 3 in the study). 
 
To calculate the amplitude of the remaining respiratory phases, four points at equal 
distances divided the interval between the calculated 50% and 0% average amplitudes. The 
first point specified the amplitude of the 40% and 60% phases, the second point specified 
the amplitude of the 30% and 70% phases, the third point specified the amplitude of the 
20% and 80% phases, and finally, the fourth point specified the amplitude of the 10% and 




Figure 3-8. After calculation of the amplitude of EI (0%) and EE (50%) phases, to calculate 
the amplitude of the remaining respiratory phases, four points at equal distances divided 
the interval between the calculated 0% and 50% average amplitudes (signals in the image 
from patient no. 3 in the study). 
 
To set the amplitude of displacement at 50% phase (EE) at zero (reference), the magnitude 
of average amplitude at 50% phase was subtracted from all respiratory phases. Figure 3-9 




Figure 3-9. Illustration of calculated average amplitude of each respiratory phase for patient 
no. 3 in the study. 
 
 
3.2.3. 4DCT Image Processing 
Image registration can provide useful information on the displacement of the anatomical 
elements from one respiratory phase to the other. For most organs in the body, such as 
lung, large number of degree of freedom (DOF) is required to explain the deformations 
with required accuracy. Deformable (non-rigid) registration can describe the deformation 
by a large number of free parameters, contrary to affine (rigid) registration, which can work 
only with a limited number of free parameters [95].  
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In this study, deformable image registration (DIR) was performed between a reference 
respiratory phase and other phases. The EE phase was considered as the reference phase. 
The better reproducibility of the EE phase was the reason for this selection. The Horn and 
Schunk optical flow registration algorithm [96] was chosen for its accuracy and 
computational efficiency [97]. Optical flow algorithms represent the pattern of movement 
velocities of intensities in an image. Therefore, they work with the relative velocities of the 
objects in an image to an observer. If Im and If  represent the moving image and the fixed 
image respectively, the deformation vector field V is registering Im to If : 
𝐼𝑓 = 𝐼𝑚 ∘ 𝑉 ≡  𝐼𝑚(𝑥 − 𝑉(𝑥)) (2.1) 
where, ∘ is composition operator and 𝑥 is the spatial coordination. The above equation can 
be solved by adding the regularization constraint function, R. The system cost function E 
is: 







In most optical flow algorithms 𝑅(𝑉) = 𝑡𝑟((∇𝑉)𝑇(∇𝑉)), where 𝑡𝑟( ) is matrix trace 
operator. In cases that |𝑉| is small, Tylor expansion of the first order term of the above 
equation is used: 






where, 𝐼𝑑 = 𝐼𝑓 − 𝐼𝑚 , ∇ is the gradient operator and ⋅ is the inner vector product. In Horn 
and Schunk optical flow algorithm the following iterative solution is used to solve the cost 
function equation: 
 41 
𝑉𝑛+1 =  ?̅?𝑛 − 




where, 𝑉𝑛 is the deformation vector field (DVF) at iteration 𝑛 and ?̅?𝑛 for each pixel is 
averaged over neighboring pixels. Each DVF demonstrates the displacement of a voxel 
from the reference respiratory phase to another.  
DIRART [98] software package was used to perform image registration. Nine image 
registration were performed between the reference phase and nine other respiratory phases.  
To perform each registration, in DIRART, after loading the images, a priori alignment of 
fixed and moving images was performed by the center of objects in both images. In order 
to increase the accuracy of the registration and to save the small features in the image, 
downsampling was performed by a multigrid approach with a maxfilter [97]. Then, the 
Horn and Schunk optical flow was selected as the registration algorithm. The result of DIR 
between the reference image (EE) and the image at time point 𝑖 is a set of DVFs. Figure 
3-10 represents a schematic view of the resultant DVFs after registering EI (or 0%) phase 
with EE (or 50%) phase on coronal view for one of the patients in the study.  
 
 
Figure 3-10. Illustration of a schematic view of DVFs resulting from registration of EI (or 
0%) and EE (or 50%) phases on the coronal view of one of patient no. 4 in the study. The 




The resultant nine DVF sets were exported from DIRART to Matlab workspace for further 
steps of the study. Each DVF set is imported into Matlab workspace as a 3D matrix with 
the size of the registered 4DCT images, i.e., 512 × 512 × 𝑛. Where, 𝑛 is the number of 
slices in the image.  In order to increase the speed of the computation, the majority of the 
DVFs of the voxels that did not include the lung were removed prior to the next steps of 
the study by the following steps. Since the 0% respiratory phase (EI) is the phase with 
lungs at their maximum size compare to other phases, first, the whole lung was segmented 
from EI phase. An active contour method was chosen to segment the lung. Initial seed mask 
was created by segmenting the lung in two perpendicular slices; one slice in XY direction 
(transverse) and one slice in XZ direction (coronal). Segmentation of two slices was 
performed by the threshold method and morphological operators. The two segmented slices 
are then used to make a 3D seed mask. Finally, the lung in the 3D volume is segmented by 
active contour method. After segmentation the value of all pixels that do not contain lung 
will be zero. By identifying the indices of all voxels with non-zero value, a cuboid volume 
was found that contains the whole lungs in 0% respiratory phase. Then, 20 voxels were 
added to the cuboid in each direction to make sure that all of the necessary DVFs are 
included in the selected matrix. Finally, in the DVF matrix, all of the voxels with the same 
indices as the cuboid were selected as a new DVF matrix.  
The computed DVFs in DIRART are in unit of voxel (not in physical unit like cm or mm). 
Therefore, they were scaled by the size of the voxels in the image which is 
1.17188 × 1.17188 × 3. After performing some simple matrix operations the vector of 
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deformation fields at time point 𝑖 was written as 𝑉𝑖 = [?⃗?1,𝑖 , ?⃗?2,𝑖 , … , ?⃗?𝑀,𝑖]
𝑇
, where 𝑀 is the 
number of voxels in the image.  
 
3.2.4.  Constructing the Correspondence Model 
Principal Component Analysis is a mathematical technique for finding the pattern of data. 
Also, PCA can reduce the number of variables in a high dimensional dataset to a smaller 
number of linearly uncorrelated variables named principal components while keeping the 
important information.  
To find the correlation between the internal motion and surrogate signals, PCA was used 
to fit the correspondence model [89]. PCA also has the advantage of removing the noise of 
the imaging data and co-linearity of surrogate data.  
In PCA framework, the covariance matrix was constructed and its eigenvectors were 
obtained. Those eigenvectors with the largest eigenvalues are the principal components 
used in the model. To construct the data covariance matrix, first, motion vectors at each 
time point 𝑖 were constructed by combining the deformation field vector and surrogate 
signal vector, 𝑝𝑖 = [𝑉𝑖 , 𝑆𝑖]. The motion vectors have been rewritten as 𝑝𝑖 =
[𝑣1,1,𝑖 , 𝑣1,2,𝑖 , 𝑣1,3,𝑖 , … 𝑣𝑚,𝑗,𝑖 , … , 𝑣𝑀,3,𝑖 , 𝑠1,𝑖 , 𝑠2,𝑖]
𝑇
. Where, 𝑣𝑚,𝑗,𝑖 is the 𝑗𝑡ℎ (𝑗 =  1 −  3 for 𝑥, 
𝑦 and 𝑧) displacement components of voxel 𝑚 at time point 𝑖 (𝑖 =  1 −  10, for 10 
respiratory phases).  





𝑖=1 ), matrix 𝑃 =
[?̃?1, ?̃?2, … , ?̃?𝑖 , … , ?̃?10] was constructed, where 𝑝𝑖 = 𝑝𝑖 − ?̅?  is the mean centered motion 
vector at 𝑖. The goal was to find the eigenvectors of the covariance matrix 𝑃𝑃𝑇. The size 
 44 
of the 𝑃 is (3𝑀 +  2) ×  10 and in our study 𝑀 is around 107. Therefore, the size of the 
covariance matrix is large and calculating its eigenvectors is computationally expensive. 
However, since the total number of time points is smaller than the number of voxels in 
each image (10 <  𝑀),  𝑃𝑃𝑇 has only 10 −  1 =  9 eigenvectors with non-zero 
eigenvalues.31 Consider that 𝐴 is the eigenvector of the 𝑃𝑇𝑃 with eigenvalue of 𝛼 (𝑃𝑇𝑃𝐴 =
𝛼𝐴). By multiplying both sides by 𝑃 we have 𝑃𝑃𝑇𝑃𝐴 = 𝛼𝑃𝐴. This shows that 𝐸 =  𝑃𝐴 is 
an eigenvector of 𝑃𝑃𝑇. Therefore, instead of calculating the eigenvectors of 𝑃𝑃𝑇, we can 
calculate the eigenvectors of the matrix 𝑃𝑇𝑃 which is a much smaller matrix (10 ×  10) 
and multiply them by 𝑃. The mean centered motion vector at an arbitrary time 𝑡 is a 
weighted linear combination of the first 𝐺 eigenvectors with the largest eigenvalues 
(principal components), as shown in equation 1: 
?̃?𝑡 ≈ ∑ 𝑤𝑔𝐸𝑔
𝐺
𝑔=1   (2.5) 
Equation 2.5 can be re-written as equation 2.6:  
?̃?𝑡  ≈ 𝐸𝑊 (2.6) 
where, E is the matrix of the first 𝐺 eigenvectors and 𝑊 is the matrix of their related 
weights. Equation 2.6 can be split into two individual equations (2.7 and 2.8):  
?̃?  ≈  𝐸𝑢𝑊 (2.7) 
?̃?   ≈  𝐸𝑠𝑊 (2.8) 
where, Eu and Es are built from the upper 3𝑀 rows and lower 2 rows of matrix 𝐸, 
respectively. W can be eliminated from above equations if the inverse matrix 𝐸𝑠
−1 exists: 




−1 exists if the number of rows in 𝐸𝑠  would be equal to or larger than the number of 
columns. In other words, the number of eigenvectors that are used in equation 1 should not 
exceed the number of surrogate signals.  
The motion vector at time 𝑡 can be calculated from new surrogate signal values by equation 
2.10:  
 
𝑉𝑡  = ?̅?𝑖
 
+ 𝐸𝑠𝐸𝑠














𝑖=1 . The components of the vector 𝑆𝑛𝑒𝑤 =
[𝑠1,𝑡 , 𝑠2,𝑡]
𝑇
are the new values of the surrogate signals, i.e. the inputs of the correspondence 
model.  
 
3.2.5. Surrogate Signals as the Model Input 
During treatment, CatalystHD recorded the primary and secondary signals. The location of 
the primary and secondary signals on the patient’s skin on treatment day are the same as 
their location on the CT simulation day. After the treatment the signals were exported from 
the C-RAD software and imported to Matlab. Figure 3-11 illustrates the primary and 
secondary signals recorded by CatalystHD for one of the patients in the study.  
The average amplitude of 50% respiratory phase (EE) was calculated for both primary and 
secondary signals (with the same method that was explained before) and was set as the 
baseline (zero). Then, the primary and secondary signals were entered into the 
correspondence model as input. 
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Figure 3-11. Illustration of primary and secondary signals recorded on the treatment day 
for patients no. 3 in the study. 
 
 
3.2.6. Respiratory Phantom 
To evaluate the accuracy of the correspondence model, the model was tested on a 
respiratory phantom. A CIRS Xsight Lung Tracking Phantom kit (CIRS, Norfolk, VA) was 
used to model the respiratory motion (Figure 3-12). 
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Figure 3-12. CIRS Xsight Lung Tracking Phantom kit. 
 
A 25 mm diameter spherical target is embedded inside a 63.5 mm diameter lung density-
equivalent rod. As the surrogate platform moves vertically, the rod moves 10 mm linearly, 
and rotates with a rotational amplitude of 10.3 degrees in the phantom. A complete cycle 
is defined as an EE followed by an EI. Each complete cycle takes 4.5 s. The center of the 
sphere moves 10 mm in superior-inferior (SI) direction, 0.24 mm in anterior-posterior (AP) 
direction, and 2.77 mm in left-right (LR) direction. These values were considered as ground 
truth for the phantom study.  
A thin wooden board, approximately 1 mm thick, was attached to the top of the phantom 
platform to expand its area. A large skin-like silicone pad was placed on the phantom to 
simulate skin and, to cover the board on the surrogate platform and connect it to the 
phantom. The primary signal point was placed on the surrogate platform, and the secondary 
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signal was placed on the part connecting the platform to the phantom. The isocenter was 
considered at the target sphere centroid.  
The phantom 4DCT and surrogate signals were acquired, and the correspondence model 
was constructed for the phantom. Figure 3-13 illustrates the setting of the phantom on the 
CT scanner’s couch.  
 
 
Figure 3-13. A CIRS Xsight Lung Tracking Phantom as positioned on the CT scanner  
couch. A large skin-like silicone pad was placed on the phantom to cover the surrogate 





The phantom was then positioned on the treatment couch of a Varian Truebeam LINAC 
(Varian Medical Systems, Palo Alto, CA). Figure 3-14 shows the setup of the phantom on 
the linear accelerator couch. The primary and secondary signals were recorded by 
CatalystHD and were placed into the model to calculate the target sphere centroid’s motion 
in SI, AP and LR directions. The average and standard deviation of displacement between 
all consecutive EE and EI phases were calculated and compared with the ground truth. 
 
 
Figure 3-14. A CIRS Xsight Lung Tracking Phantom as positioned on the linear accelerator 
couch. A large skin-like silicone pad was placed on the phantom to cover the surrogate 
platform and connect it to the phantom. The red and light green circles on the silicon pad 




3.2.7. Patient Data  
After recording the surrogate signals and 4DCT images of each patient on the simulation 
day, the correspondence model was constructed. The surrogate signals were also recorded 
by CatalystHD during each treatment session and entered into the model to calculate the 
location of the voxel of interest during treatment. Table 3-1 shows the characteristics of 
the patients in the study. The last two columns of Table 3-1 shows patients’ breathing types. 
Periodic combination of shallow and deep breathing patterns was considered irregular 
breathing and uniform respiration was considered regular breathing. 
 
Table 3-1. Characteristics of the patients in the study. 





1 F 77 Upper right lung Irregular Irregular 
2 M 70 Upper right lung Regular Regular 
3 F 59 Lower left lung Regular Regular 
4 M 62 Lower right lung Irregular Regular 
5 M 50 Lower right lung Regular Regular 
 
 
Two of the patients (patients 1 and 2) had tumors that were visible in approximately half 
of the 2D projections. Therefore, it was possible to calculate the tumor range of motion 
from 2D projections as ground truth for the model. For those patients, the motion trace of 
the tumor center was calculated by the model in the SI, AP, and LR directions. In the 
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resultant trace of displacement vs. time in each direction, the magnitude of displacement 
of the tumor center between any two consecutive EE and EI phases, and their average and 
standard deviation, were calculated. The tumors of the other three patients (patients 3, 4, 
and 5) were not visible in the 2D projections, due to their proximity to other structures such 
as diaphragm. Therefore, the motion trace of the apex of the diaphragm on the ipsilateral 
side of the tumor was calculated by the model in the same three directions. In the resultant 
trace of displacement vs. time in each direction, the magnitude of displacement of the 
diaphragm apex between any two consecutive EE and EI phases, and their average and 
standard deviation, were calculated. 
At each treatment session, just prior to the treatment delivery, a cone-beam CT (CBCT) 
image was acquired using the Varian LINAC’s CBCT system. All CBCT images were 
acquired using “thorax” protocol (1 min, 15 frames/s, 360o) in half-fan mode at 125 kV 
and 15 mA. During each CBCT acquisition, 895 two-dimensional (2D) projections were 
acquired. The 2D projections were used to calculate the ground truth on the day of 
treatment. To calculate the ground truth from 2D CBCT projections, first, the EE and EI 
projections were identified. To find the EE and EI projections, the patient’s respiratory 
signal for the CBCT period was extracted using Amsterdam Shroud (AS) Image [99].  
In this technique, the position of the diaphragm is used to extract the patients respiratory 
signal. First, the logarithm of each individual projection is applied. Now the value of each 
pixel in the image is proportional to the radiological thickness. To distinguish patient from 
air a threshold is applied to the logarithmic image (Figure 3-15).  
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In the next step, to intensify the diaphragm, the derivative of the image is taken in the SI 
direction using a Sobel gradient operator. In Sobel gradient operator, the pixel’s gradient 
is a weighted sum of pixels in a 3 × 3 pixel neighborhood (Figure 3-16). 
 
 
Figure 3-15. The logarithmic 2D projection of one of patient no.3 in the study in EE phase 
after applying a threshold. 
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Figure 3-16. The derivative of the image in Figure 3-15 is taken in the SI direction using a 
Sobel gradient operator. 
 
A threshold is applied to the derivative image to separate the diaphragm-like transitions 
(Figure 3-17, left). Then, the resultant image is collapsed onto its craniocaudal (SI) axis by 





Figure 3-17. Applying a threshold to the image in Figure 3-16 (left) and it projection on 
craniocaudal axis at the (right). 
 
The AS image is constructed by combining all 1D projections view by view. A horizontal 





Figure 3-18. The Amsterdam Shroud image constructed for one of the patients in the study. 
 
 
After cutting the diaphragm region out of the AS image (Figure 3-19.a), diaphragm region 
is collapsed onto the temporal (horizontal) axis by summing over all pixel intensity values 
in each column (Figure 3-19.b) [100]. This resultant signal has two components. One 
component is mostly due to respiration and the other component is due to other factors 
such as traversing the x-ray beam through varying thickness materials as the gantry is 
rotating around the patient. After applying a high-pass filter the respiratory signal is 
extracted (Figure 3-19.c). On the respiratory signal extracted from diaphragm motion, the 
projections that are on the maxima of the signal are EE phases and those on the minima of 




Figure 3-19. Diaphragm region was cut from the AS image (a). Diaphragm region is 
collapsed onto the temporal (horizontal) axis by summing over all pixel intensity values in 
each column (b). The respiratory signal is obtained after applying a high-pass filter. Each 
red point on the signal is representing a projection (c). 
 
 
For patients 1 and 2, whose tumors were visible in a sufficient number of projections, a 
radiation oncologist drew the contour of the tumor on the 2D projection images (Appendix 
A). Then the centroid position of the tumor was localized in those images [101]. The 
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displacement of the centroid in projection images could be measured in two directions: the 
axial direction, which is along the SI axis of the imager, and the tangential direction, which 
is perpendicular to the axial direction. Since for these two patients, the CBCT center of 
rotation is at the tumor center, the displacement of the centroid of the tumor in the axial 
direction is a scaled version of the displacement in the SI direction.  The displacement in 
the tangential direction is a combination of displacements in the AP and LR directions.  
However, for projection angles close to LR or right-left (RL), the displacement of the 
centroid is approximately a scaled version of its AP displacement, and for projection angles 
close to AP or posterior-anterior (PA), the centroid’s displacement is approximately a 
scaled version of its LR displacement. The position of the centroid was calculated in all EE 
and EI projections for which the tumor was visible to the radiation oncologist. The 
difference of centroid position in the axial direction between any two consecutive EE and 
EI was measured, and their average and standard deviation were calculated. For AP and 
LR directions, the closest consecutive EE and EI projections to LR/RL and AP/PA were 
identified and the differences of centroid position in tangential direction were calculated. 
For patients 3, 4, and 5 (for whom the displacement of their apex of the diaphragm was 
calculated by the model), the apex of the diaphragm was located manually on all EE and 
EI projections. After scaling and applying the fan-beam geometry, the average and standard 
deviation of the apex of the diaphragm were calculated as ground truth in SI direction. In 
addition, the projections near LR/RL and AP/PA were identified, and the displacement of 
the apex in the tangential direction was calculated as ground truth in AP and LR directions. 
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3.3. Results 
3.3.1.  Respiratory Phantom 
Figure 3-20 shows the location of the target sphere centroid calculated by the model for 
the respiratory phantom in the LR, AP, and SI directions. The direction of the motion 
matches the true direction of the centroid motion along all three axes. The magnitude of 
the average and standard deviation of the displacement in each direction is compared with 
the ground truth data in Table 3-2. The error is less than 1 mm in the LR and AP directions, 
and less than 2 mm in the SI direction. The main component of this error is the deformable 
image registration accuracy. Figure 3-21.a shows the PCA eigenvalue spectrum for the 
respiratory phantom. To fit the correspondence model, only the eigenvector associated with 
the first (largest) eigenvalue was used.  
 
 
Figure 3-20. Location of the target sphere centroid calculated by the model for the 
respiratory phantom. The direction of the motion matches the true direction of the centroid 
motion along all three axes. 
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Table 3-2. The magnitude of the average and standard deviation of the displacement in 









LR 2.77 ± 0.1 2.21 ± 0.01 0.56 
AP 0.24 ± 0.1 0.14 ± 0.00 0.10 




Figure 3-21. PCA eigenvalue spectrum for the respiratory phantom (a) and for patient no. 
5 (b). 
 
3.3.2.  Patient Data  
Figure 3-21.b shows the eigenvalue spectrum for one of the patients. For all patients, only 
the eigenvector associated with the largest eigenvalue was used to construct the 
correspondence model.  
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Figure 3-22 shows the location of the apex of the left diaphragm during part of the treatment 
for patient 5. The direction of the motion matches that of the diaphragm apex motion in 2D 
projections in all three directions. The magnitude of the average and standard deviation of 
the displacement in LR, AP, and SI directions are compared with the ground truth in tables 
2.3, 2.4, and 2.5, respectively. Since the measurement of the ground truth in LR and AP 
directions are only possible in one of the complete respirations during CBCT acquisition, 
there is no calculated standard deviation for ground truth in these two directions. However, 
in the SI direction, the tumor center or the apex of the diaphragm could be located in several 
consecutive EE and EI projections. Therefore, the standard deviation was calculated for 
ground truth in SI direction. Table 3-5 shows the number of complete respirations that were 
used to measure the ground truth in SI direction for each patient.  
 
 
Figure 3-22. Location of the left diaphragm apex during the radiation delivery calculated 




For all patients, the error in the LR and AP directions is less than 1 mm (Table 3-3 and 
Table 3-4). In the SI direction, for all patients except patient 4, the error is less than 2 mm 
(Table 3-5). For patient 4, the error in SI direction is 3.13 mm. For patient 4, the average 
of the patient’s skin displacement in all respiratory phases for secondary signal in 4DCT 
acquisition day was very close to the treatment day. However, for the primary signal, the 
average of the patient’s skin displacement in all respiratory phases in treatment day was 
significantly larger than the 4DCT acquisition day. The fact that the primary signal was 
recorded larger on treatment day than the 4DCT acquisition day might be the reason for 
slightly larger error for this patient in SI direction. The results show that the model’s 
accuracy is independent of the patient’s type of breathing or irregularities. 
 
Table 3-3. The average and standard deviation of the tumor center or diaphragm apex 
displacement during treatment in LR direction calculated by the model for each patient 
compared with the ground truth.  








1 Tumor Center 1.97 2.55 ± 0.60 0.58 
2 Tumor Center 1.50 0.92 ± 0.10 0.58 
3 Diaphragm Apex 1.05 1.17 ± 0.21 0.12 
4 Diaphragm Apex 1.49 1.22 ± 0.19 0.27 




Table 3-4. The average and standard deviation of the tumor center or diaphragm apex 
displacement during treatment in AP direction calculated by the model for each patient 
compared with the ground truth. 








1 Tumor Center 0.57 0.57 ± 0.13 0.00 
2 Tumor Center 6.66 6.31 ± 0.71 0.35 
3 Diaphragm Apex 0.24 0.14 ± 0.00 0.10 
4 Diaphragm Apex 1.24 0.96 ± 0.05 0.28 
5 Diaphragm Apex 1.88 2.46 ± 0.19 0.58 
 
 
Table 3-5. The average and standard deviation of the tumor center or diaphragm apex 
displacement during treatment in SI direction calculated by the model for each patient 
compared with the ground truth. Number of the respirations indicates the number of 
respirations used to calculate the ground truth. This is the number of all consecutive EE 
and EI projections for which the tumor center or the apex of the diaphragm was visible to 
the eyes. 










1 Tumor Center 4.22 ± 0.65 3 3.46 ± 0.80 0.76 
2 Tumor Center 5.13 ± 0.93 7 5.40 ± 0.58 0.27 
3 Diaphragm Apex 12.11 ± 2.47 9 12.55 ± 2.05 0.44 
4 Diaphragm Apex 12.55 ± 2.81 7 15.68 ± 2.49 3.13 
5 Diaphragm Apex 20.06 ± 2.35 6 18.55 ± 1.45 1.51 
 63 
The systematic uncertainty of each step in the model construction is presented in Table 3-6. 
The systematic uncertainty for the Sentinel system is considered as the noise and drift error 
of the amplitude in the respiratory signal and depends on the patient’s weight. For patients 
weighing between 69 to 91 kg, the estimated root mean square error (RMSE) for the 
Sentinel system is 0.5 mm [102]. In DIRART software, the registration accuracy of the 
Horn and Schunck algorithm is around 0.5-1.5 mm [98]. Here, to calculate the total 
uncertainty, the upper bound (1.5 mm) was employed as a conservative estimate. Finally, 
the RMSE of tracking accuracy of the CatalystHD system is 0.11-0.24 mm [103], and the 
upper bound (0.24 mm) was used in the calculation of the total uncertainty. 
 
Table 3-6: Systematic uncertainty for each step of the model construction and the 
calculated total systematic uncertainty. 
 
Uncertainty Source RMSE (mm) 
Sentinel 0.50 







3.4. Discussion  
This work describes the development of a patient-specific correspondence model to 
localize and track tumors in the thorax during radiation therapy. This model is constructed 
using 4DCT images of the patient and the displacement of two points on the patient’s skin 
surface as the surrogate signals. The surface imaging system employed to record the 
surrogate signals is a dose-free and non-invasive technology without any special breathing 
instructions for the patients. Patients can breathe normally during both the 4DCT 
acquisition and treatment.  
To construct the model, amplitude-sorted 4DCT images are used, which have several 
benefits. The amplitude-sorted algorithm does account for hysteresis and irregular 
breathing. Moreover, the amplitude-binning algorithm reduces the artifacts in 4DCT 
images. This improves the quality of internal motion datasets and, therefore, yields more 
precise image registration results. In general, image registration accuracy is an important 
component of the accuracy of the model.  
The results of our study confirm that there is a correlation between external and internal 
anatomy motion, which is consistent with the results of studies performed by Chi et al. 
[82], Fayad et al. [104], and Beddar et al. [105]. 
Fassi et al. [79] proposed a patient-specific respiratory motion model derived from 4DCT 
images of the patient. In their model, parameters such as baseline, amplitude, and phase 
are updated at each treatment session using in-room radiography acquisition and optical 
surface imaging. For updating the baseline, the mid-position 4DCT image has to be 
registered with CBCT image, which has a lower quality than the 4DCT image, and that 
 65 
affects the accuracy of the model. Also, using a deformable mesh registration algorithm 
for extracting the amplitude and phase from the surrogate signal is a time-consuming 
process and makes it hard to expand the model’s application to real-time tracking. In our 
study, the EE phase is considered as reference (baseline). Therefore, the magnitude of the 
skin displacement is considered as the surrogate signal, and the model delivers the 
displacement of the anatomy of the interest with respect to the EE phase. Since recording 
of the surrogate signals with CatalystHD is simple and continuous there is a potential to 
expand the application of the model to real-time tracking. 
Fayad et al. [106] developed a 4D global respiratory motion model to correlate the internal 
motion to patient’s external surface motion. Their motion model is adapted on each patient 
by two static CT images (at full expiration and full inspiration), and patient’s surface maps 
are extracted from either CT images or optical imaging devices. The evaluation of their 
model showed promising results for six patients. However, acquiring CT images at full 
expiration and full inspiration requires breath-hold technique, which is not possible for 
some patients [107]. 
The results of testing the model on a phantom and five patients showed a primary validation 
of our study. However, testing the model on a larger population of patients can examine 




3.5. Conclusions  
In this study, we developed a patient-specific correspondence model to locate the 3D 
position of the tumor or any other anatomy of interest in the thorax during radiation therapy. 
The localization error in both the LR and AP directions is less than 1 mm, and is less than 
4 mm in the SI direction. The accuracy of results is independent of the patient’s breathing 



















4.Summary and Future Work 
4.1. Summary 
The aim of this work was to find methods to reduce the impact of respiratory-induced 
motion in radiation therapy of lung cancer patients.  
First, the application of combining stereotactic body frames with a surface imaging system 
for patient positioning in stereotactic body radiotherapy (SBRT) of lung cancer was 
evaluated. Combining the use of a surface imaging system with stereotactic body frames 
adds another level of accuracy to patient setup and provides monitoring of the movements 
during treatment. However, the presence of the compression plate and respiratory belt 
prevents the monitoring of respiratory signals.  
In the second part of this work, a correspondence model was developed to track the tumors 
in the lung during radiation delivery. Based on previous studies, we assumed that there is 
a patient-specific correlation between the internal and external motion for each patient on 
the thoracic area. To find this correlation, two types of data were employed. First, 4DCT 
images acquired from the patient on the simulation day, and second, the displacement of 
two points on the patient’s skin surface on the chest area as surrogate signals during 4DCT 
image acquisition. Image and signal processing procedures were applied to the acquired 
data to extract the internal and external motion data. PCA was used as a mathematical tool 
to fit the correspondence model on the internal and external motion data. The final result 
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is a patient-specific correspondence model that can calculate the location of the tumor 
during radiation delivery when receiving the surrogate signals as input.  
The accuracy of the model was evaluated on a respiratory phantom and five lung cancer 
patients. The accuracy of the localization in LR and AP directions were less than 1 mm for 
both phantom and patient study. In the SI direction, the localization error was less than 2 
mm for the phantom and less than 4 mm for all patients.  
 
 
4.2. Future Work 
 
The correspondence model presented in this work can localize any voxel in the volume 
selected for 4DCT acquisition. Therefore, its application can be expanded to localize 
tumors or any other anatomical structures of interest in the thorax or abdomen. 
This model can be used for inter-fraction studies during which the patients’ weight, 
anatomy, and type of breathing may change. The average, maximum, and minimum ranges 
of the tumor motion in all directions can be calculated by the model after each session and 
compared with previous sessions to see if there is any need to modify the treatment plan. 
Also, 4D CBCT images of the patients can be potentially constructed to update the model.  
Since the recording of the surrogate signals is continuous, the application of this model can 
be expanded to real-time tumor tracking. In that case, the time delay between recording the 
surrogate signals and calculation of the tumor location has to be assessed.  
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The results of testing the model made in this study showed a primary validation for 
localizing the tumors in the lung. Testing the model on a larger population of patients with 
more variety of breathing types and tumor locations will examine the accuracy of the 
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